Skip to content

Evaluating tools to communicate scleroderma research results to patients - SPIN-CLEAR Trial Series PPI Sub-study #1

A randomized controlled trial to compare the effectiveness of dissemination tools to share research results with patients - A SPIN-CLEAR Trial Series Patient and Public Involvement Statement Sub-study #1

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17218321
Enrollment
118
Registered
2025-10-27
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of research dissemination tools to people living with systemic sclerosis (SSc

Interventions

Current interventions as of 23/02/2026: The investigators will use the multinational SPIN Cohort to conduct a series of RCTs to compare tools among people with systemic sclerosis, or scleroderma. Th

Sponsors

Jewish General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Current key inclusion criteria as of 23/02/2026: Eligible participants will include SPIN Cohort participants and others with systemic sclerosis (SSc; also known as scleroderma) who participated in previous SPIN-CLEAR trials or a SPIN online patient-oriented research event. 1. Enrollment in SPIN Cohort, which requires a systemic sclerosis (SSc) classification by a site physician based on 2013 American College of Rheumatology/European League Against Rheumatism criteria, =18 years old, being fluent in English or French, and have completed one SPIN Cohort assessment in the last year. 2. External enrollment with patient-reported physician classification of SSc and aged 18 years or older. _____ Previous key inclusion criteria: 1. Enrollment in SPIN Cohort, which requires a systemic sclerosis (SSc) classification by a site physician based on 2013 American College of Rheumatology/European League Against Rheumatism criteria, =18 years old, being fluent in English or French, and have completed one SPIN Cohort assessment in the last year. 2. External enrollment with patient-reported physician classification of SSc and aged 18 years or older.

Exclusion criteria

Exclusion criteria: Patients not able to access or respond to questionnaires via the internet

Design outcomes

Primary

MeasureTime frame
1. Relevance of the research: "The information in this plain-language summary is relevant to me”. Response options = 0-10 numerical rating scales (0 = strongly disagree, 10 = strongly agree). Time frame: immediately post-intervention (intervention and outcomes in one login - outcomes approx.. 30 min after randomization). 2. Trustworthiness of the research: “I trust that the information in this plain-language summary is accurate and unbiased”. Response options = 0-10 numerical rating scales (0 = strongly disagree, 10 = strongly agree). Time frame: immediately post-intervention (intervention and outcomes in one login - outcomes approx.. 30 min after randomization)

Secondary

MeasureTime frame
1. Information completeness: “The information presented in the plain-language summary told me everything I wanted to know about the study”. Response options = 0-10 numerical rating scales (0 = strongly disagree, 10 = strongly agree). Time frame: immediately post-intervention (intervention and outcomes in one login - outcomes approx. 30 min after randomization). 2. Understandability: “The information presented in the plain-language summary was easy to understand”. Response options = 0-10 numerical rating scales (0 = strongly disagree, 10 = strongly agree). Time frame: immediately post-intervention (intervention and outcomes in one login - outcomes approx. 30 min after randomization). 3. Pleased to have received results: “I am glad that I received the study results”. Response options = 0-10 numerical rating scales (0 = strongly disagree, 10 = strongly agree). Time frame: immediately post-intervention (intervention and outcomes in one login - outcomes approx. 30 min after randomization). 4. Intention to participate in future studies: “In the future, I would agree to participate in a similar study to the one presented in the plain-language summary”. Response options = 0-10 numerical rating scales (0 = strongly disagree, 10 = strongly agree). Time frame: immediately post-intervention (intervention and outcomes in one login - outcomes approx. 30 min after randomization).

Countries

Canada

Contacts

Public ContactBrett Thombs
brett.thombs@mcgill.ca+1 (0)514 340 8222

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026